Page 7 - Oxford University

Govt to ensure regulatory facilitation for Serum's Covid-19 vaccine trials

Serum Institute of India, the largest vaccine manufacturer in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it gets ready.

We want to price Covid-19 vaccine below Rs 1,000: Serum Institute CEO

Pune's Serum Institute of India is placing its bets on the Oxford-AstraZeneca vaccine candidate AZD1222

Oxford Covid vaccine trial raises hopes; India testing 10,175/1 mn people

India, which has a population over four times as big as the US', has conducted 14,381,303 tests in total, or just 10,175 tests per 1 million people

Indian medical experts hail Oxford trial results for Covid-19 vaccine

From clinicians to pathology experts, doctors in the country feel the Oxford trials have been the 'most transparent' one by far

Oxford-Astra Covid-19 vaccine shows dual immune action, says researcher

Study shows the vaccine is safe, but it is still too soon to know if it can stop people from being infected

Covid-19 vaccine: Oxford candidate safe, shows immune response in trial

The preliminary results of the phase 1-2 trial, published in The Lancet journal, involved 1,107 healthy adults, and found that the vaccine induced an immune response both via antibodies and T-cells

Britain signs deals with Pfizer, BioNTech, Valneva for Covid-19 vaccines

Deals follow a previously announced agreement with AstraZeneca for the firm to produce 100 million doses of its potential vaccine being developed in partnership with the University of Oxford

Covid-19: Vaccine firms give Moderna a shrug, say no rush on tie-ups

Most players that Business Standard spoke to said they would be concentrating on their own vaccine candidates or the current tie-ups that they have

Oxford University Covid-19 vaccine raises hopes with strong trial results

Blood samples taken from a group of UK volunteers given a dose of the vaccine showed that it stimulated the body to produce both antibodies and killer T-cells

Positive news on Oxford's Covid-19 vaccine may be announced on Thursday

AstraZeneca's experimental vaccine is probably the world's leading candidate and most advanced in terms of development, the World Health Organization's chief scientist said in June

Lakshmi Mittal gifts GBP 3.5 mn to Oxford for developing Covid-19 vaccine

Lakshmi Mittal said, "This year has been a wake-up call to the world to be better prepared for pandemics, which, as we have all experienced, can cause massive social and economic disruption."

Mamata Banerjee invited to speak at Oxford Union debate next year

West Bengal Chief Minister and Trinamool Congress supremo Mamata Banerjee has received an invitation to speak at The Oxford Union Debate next year

Covid-19 crisis: Race to develop vaccine gets a booster as field widens

On Thursday, CDSCO also approved Zydus Cadila's plasmid DNA vaccine candidate ZyCoV-D, developed at its Vaccine Technology Centre in Ahmedabad.

Covid-19: Brazil announces agreement with UK to produce Oxford vaccine

The Brazilian Ministry of Health announced an agreement with the UK to acquire technology to locally produce a Covid-19 vaccine currently being developed by the Oxford University and AstraZeneca

Human trial begins of Imperial College London's candidate Covid-19 vaccine

Imperial College London's vaccine candidate is being developed and trialled with the help of more than £41 million in funding from the UK government and a further £5 million in philanthropic donations

WHO suggests usage of dexamethasone steroid for critical Covid-19 cases

The preliminary trial was conducted over random 2,100 hospitalised Covid-19 patients, and about 4,300 hospitalized Covid-19 patients who were randomized to receive the usual standard of care

Part of a humanitarian cause: Indian-origin scientist on Covid vaccine plan

Chandrabali Datta, who was born in Kolkata, works in the Clinical Biomanufacturing Facility at the Oxford University's Jenner Institute

Oxford University Covid-19 vaccine trial has 50% chance of 'no result'

The University of Oxford last week announced that the advance human trial of the vaccine will involve up to 10,260 volunteers across the UK

Oxford University's Covid-19 vaccine moves to next stage of human trials

The first phase of the trial began last month with 1,000 healthy adults aged 55 and under as volunteers.

Oxford University's candidate for coronavirus vaccine fails animal tests

The vaccine's failure to prevent the virus from attacking the rhesus macaque is a setback and kills the hope of treating humans